Celon Pharma S.A., a prominent Warsaw Stock Exchange-listed pharmaceutical company, is a powerhouse of European drug research and manufacturing. Driven by a dedicated team of over 160 scientists, the company manages an advanced pipeline spanning oncology, neurology, diabetes, and respiratory therapies, while holding a position as a global leader in dry powder inhaler technology.
To scale its specialised manufacturing capabilities, Celon Pharma signed a 20-year lease at CTPark Žilina Airport, launching a ca. €16 million investment in a purpose-built, GMP-compliant facility dedicated to filling injectable medicines.
Choosing Žilina offers critical regional advantages that enhance high-tech pharmaceutical logistics. Strategically positioned in Slovakia, the site sits just 40 km from the Czech border and 50 km from the Polish border, streamlining cross-border supply chains. Immediate access to the D1/E50 motorway corridor ensures rapid, temperature-controlled distribution across Central Europe. Furthermore, proximity to Žilina University provides Celon Pharma with a strong pipeline of local, highly skilled engineering and scientific talent.
The custom-engineered facility is fully equipped for rigorous medical production, featuring a GMP-certified cleanroom and lab space, a sterilised water tank system integrated beneath the structure, and advanced temperature-controlled cold storage.
Certified clean rooms
戰略邊境位置
Educated workforce
更多客戶案例
訂閱電子報
將工業房地產市場領導者的最新見解發送到您的收件匣。
